RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic dosage forms, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
Flawless balance sheet with solid track record.
Share Price & News
How has RPG Life Sciences's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: RPGLIFE's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: RPGLIFE exceeded the Indian Pharmaceuticals industry which returned 25.7% over the past year.
Return vs Market: RPGLIFE exceeded the Indian Market which returned -8.3% over the past year.
Price Volatility Vs. Market
How volatile is RPG Life Sciences's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall StCalculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
4 weeks ago | Simply Wall StShould You Rely On RPG Life Sciences's (NSE:RPGLIFE) Earnings Growth?
1 month ago | Simply Wall StIs RPG Life Sciences Limited's(NSE:RPGLIFE) Recent Stock Performance Tethered To Its Strong Fundamentals?
Is RPG Life Sciences undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: RPGLIFE (₹287.85) is trading above our estimate of fair value (₹283.96)
Significantly Below Fair Value: RPGLIFE is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: RPGLIFE is good value based on its PE Ratio (16.4x) compared to the IN Pharmaceuticals industry average (20.3x).
PE vs Market: RPGLIFE is poor value based on its PE Ratio (16.4x) compared to the Indian market (12.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate RPGLIFE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: RPGLIFE is overvalued based on its PB Ratio (2.7x) compared to the IN Pharmaceuticals industry average (1.7x).
How is RPG Life Sciences forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RPG Life Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Check out RPG Life Sciences's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
- RPG Life Sciences competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has RPG Life Sciences performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: RPGLIFE has high quality earnings.
Growing Profit Margin: RPGLIFE's current net profit margins (7.7%) are higher than last year (3.3%).
Past Earnings Growth Analysis
Earnings Trend: RPGLIFE's earnings have grown by 18.7% per year over the past 5 years.
Accelerating Growth: RPGLIFE's earnings growth over the past year (166.6%) exceeds its 5-year average (18.7% per year).
Earnings vs Industry: RPGLIFE earnings growth over the past year (166.6%) exceeded the Pharmaceuticals industry 17%.
Return on Equity
High ROE: RPGLIFE's Return on Equity (16.4%) is considered low.
How is RPG Life Sciences's financial position?
Financial Position Analysis
Short Term Liabilities: RPGLIFE's short term assets (₹1.3B) exceed its short term liabilities (₹825.9M).
Long Term Liabilities: RPGLIFE's short term assets (₹1.3B) exceed its long term liabilities (₹75.7M).
Debt to Equity History and Analysis
Debt Level: RPGLIFE's debt to equity ratio (2.3%) is considered satisfactory.
Reducing Debt: RPGLIFE's debt to equity ratio has reduced from 26.4% to 2.3% over the past 5 years.
Debt Coverage: RPGLIFE's debt is well covered by operating cash flow (1251.1%).
Interest Coverage: RPGLIFE's interest payments on its debt are well covered by EBIT (24.5x coverage).
What is RPG Life Sciences's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: RPGLIFE's dividend (1.39%) is higher than the bottom 25% of dividend payers in the Indian market (0.69%).
High Dividend: RPGLIFE's dividend (1.39%) is low compared to the top 25% of dividend payers in the Indian market (2.81%).
Stability and Growth of Payments
Stable Dividend: RPGLIFE's dividend payments have been volatile in the past 10 years.
Growing Dividend: RPGLIFE's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (13.7%), RPGLIFE's dividend payments are thoroughly covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Yugal Kishor Sikri (63yo)
Mr. Yugal Kishor Choturam Sikri has been Managing Director and Additional Director at RPG Life Sciences Limited since October 1, 2018 .He served as an Independent & Non-Executive Director at RPG Life Scien ...
CEO Compensation Analysis
Compensation vs Market: Yugal Kishor's total compensation ($USD292.82K) is above average for companies of similar size in the Indian market ($USD50.13K).
Compensation vs Earnings: Yugal Kishor's compensation has increased by more than 20% in the past year.
|MD & Additional Director||1.75yrs||₹22.08m||no data|
|Vice President of Finance||4yrs||no data||no data|
|Chief Operating Officer||0.33yr||no data||no data|
|Head of Legal||8.67yrs||no data||no data|
|Head of Human Resources||3.83yrs||no data||no data|
|Head of Regulatory & Project Management||no data||no data||no data|
|Business Head of API - International & Specialty||4.83yrs||no data||no data|
|Head of Domestic Manufacturing & Sourcing||3.25yrs||no data||no data|
|Head of API Operations & Procurement||3.25yrs||no data||no data|
|Site Head - F2||no data||no data||no data|
|Chief Quality Officer||1.5yrs||no data||no data|
|Business Unit Head of Domestic Formulations||no data||no data||no data|
Experienced Management: RPGLIFE's management team is considered experienced (3.3 years average tenure).
|MD & Additional Director||1.75yrs||₹22.08m||no data|
|Independent & Non-Executive Director||12.42yrs||₹615.00k||no data|
|Chairman of the Board||no data||₹600.00k||0.16% ₹8.1m|
|Independent & Non-Executive Director||16yrs||₹600.00k||no data|
|Independent & Non-Executive Director||16.75yrs||₹704.00k||no data|
|Independent & Non-Executive Director||6yrs||₹664.00k||0.0060% ₹299.6k|
|Non-Executive Director||5.5yrs||₹815.00k||no data|
|Independent & Non-Executive Director||4.75yrs||₹410.00k||no data|
|Independent Non-Executive Director||no data||no data||no data|
Experienced Board: RPGLIFE's board of directors are considered experienced (6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
RPG Life Sciences Limited's company bio, employee growth, exchange listings and data sources
- Name: RPG Life Sciences Limited
- Ticker: RPGLIFE
- Exchange: NSEI
- Founded: 1968
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₹4.952b
- Shares outstanding: 16.54m
- Website: https://www.rpglifesciences.com
Number of Employees
- RPG Life Sciences Limited
- RPG HOUSE
- 4th Floor
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|532983||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||Jun 2008|
|RPGLIFE||NSEI (National Stock Exchange of India)||Yes||Equity Shares||IN||INR||Jun 2008|
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic dosage forms, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company operates through Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients segments. It offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. The company also provides generics primarily in the area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as gastro-intestinal, pain management, cardio-vascular, and nephrology primarily under the Lomotil, Lomofen, Naprosyn, Azoran, Aldactone, and Serenace brands. In addition, it offers cosmetics, including evactive lubricating gel. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/07/15 12:55|
|End of Day Share Price||2020/07/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.